Dihydronarwedine

Dihydronarwedine is a metabolite of Galanthamine (G188500), a selective acetylcholinesterase inhibitor and therapeutic agent for the treatment and prevention of Alzheimer’s disease and disorders resulting from reduced neuronal metabolism.